Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

Stephen B Baylin1, Joyce E Ohm

  • 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Suite 530, Baltimore, Maryland 21231, USA. sbaylin@JHMI.edu

Nature Reviews. Cancer
|February 24, 2006
PubMed

Insights

Epigenetic changes, like DNA methylation, can drive cancer development by altering gene expression and creating dependencies on specific cell pathways. Reversing these epigenetic alterations may offer new strategies for cancer prevention and treatment.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Chromatin alterations are hallmarks of cancer development and progression.
  • Epigenetically mediated transcriptional silencing, often via DNA methylation, is a key mechanism.
  • These epigenetic changes may create dependencies in cancer cells on specific signaling pathways.

Purpose of the Study:

  • To explore the role of epigenetic alterations in cancer cell addiction to signaling pathways.
  • To investigate the potential of reversing epigenetic gene silencing for cancer therapy.

Main Methods:

  • Review of recent evidence on epigenetic changes in tumorigenesis.
  • Analysis of the link between epigenetic modifications and genetic mutations in cancer progression.

Main Results:

  • Epigenetic changes can 'addict' cancer cells to altered signal-transduction pathways early in tumor development.
  • This addiction facilitates the acquisition of genetic mutations, conferring selective advantages.
  • Dependence on these pathways is crucial for cancer cell proliferation and survival.

Conclusions:

  • Reversing epigenetic gene silencing presents a promising therapeutic strategy.
  • Targeting epigenetic modifications could be beneficial for cancer prevention and treatment.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...